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Sonic hedgehog signaling by the Patched–Smoothened 
receptor complex
Maximilien Murone*, Arnon Rosenthal† and Frederic J. de Sauvage*
Background: The Hedgehog (Hh) family of secreted proteins is involved in a
number of developmental processes as well as in cancer. Genetic and
biochemical data suggest that the Sonic hedgehog (Shh) receptor is
composed of at least two proteins: the tumor suppressor protein Patched (Ptc)
and the seven-transmembrane protein Smoothened (Smo).
Results: Using a biochemical assay for activation of the transcription factor Gli,
a downstream component of the Hh pathway, we show here that Smo functions
as the signaling component of the Shh receptor, and that this activity can be
blocked by Ptc. The inhibition of Smo by Ptc can be relieved by the addition of
Shh. Furthermore, oncogenic forms of Smo are insensitive to Ptc repression in
this assay. Mapping of the Smo domains required for binding to Ptc and for
signaling revealed that the Smo–Ptc interaction involves mainly the amino
terminus of Smo, and that the third intracellular loop and the seventh
transmembrane domain are required for signaling.
Conclusions: These data demonstrate that Smo is the signaling component of
a multicomponent Hh receptor complex and that Ptc is a ligand-regulated
inhibitor of Smo. Different domains of Smo are involved in Ptc binding and
activation of a Gli reporter construct. The latter requires the third intracellular
loop and the seventh transmembrane domain of Smo, regions often involved in
coupling to G proteins. No changes in the levels of cyclic AMP or calcium
associated with such pathways could be detected following receptor
activation, however.
Background
Hedgehog (Hh) is a secreted protein originally identified
in Drosophila as having a role in segment polarity,
mutants being characterized by loss of pattern and polar-
ity of embryonic segments [1]. Seven Hh homologues
have been isolated from different vertebrate species and
shown to play important roles during development
(reviewed in [2]). The best characterized of these is Sonic
hedgehog (Shh) [3–5], the activity of which regulates
dorso-ventral patterning of the neural tube (reviewed in
[6]) and the somites (reviewed in [7]), antero-posterior
patterning of the limb buds [8], and morphogenesis of
the hindgut [9].
The Smoothened (Smo) gene was also first identified in
Drosophila through a segment polarity mutant and its func-
tion appears to be required for Hh signaling [10,11]. The
subsequent cloning and analysis of Smo showed it to
encode a seven-transmembrane protein with a topology
reminiscent of the G-protein-coupled receptor (GPCR)
superfamily. Interestingly, Smo is most homologous to the
Frizzled (Fz) family of serpentine proteins. Biochemical
characterization of vertebrate homologues of Smo demon-
strated, however, that despite Smo being an activator of
the Hh pathway and sharing homology with GPCRs, Smo
does not bind Shh [12].
Patched (Ptc), another segment polarity gene encoding a
twelve-transmembrane protein, was also a candidate
receptor for Hh [13,14]. In contrast to Smo, Ptc represses
transcription of Hh target genes [15–17]. Vertebrate
homologues of Ptc bind Shh with high affinity [12,18],
providing biochemical evidence that Ptc is the Shh recep-
tor. Additional experiments indicated that Smo can be
coimmunoprecipitated with Ptc and can be found in a
ternary complex with Ptc and Shh, suggesting the exis-
tence of a multicomponent receptor for Shh [12]. Muta-
tions in human Ptc have been implicated in the basal cell
nevus syndrome, a dominant autosomal condition charac-
terized by a complex set of developmental defects and
high incidence of basal cell carcinomas (BCCs) [19,20]. In
the BCCs of basal cell nevus syndrome patients, as well as
in at least one-third of sporadic BCCs, both alleles of Ptc
are lost or mutated, suggesting that Ptc is a tumor suppres-
sor [21] and that, in the absence of Ptc, unregulated Smo
signaling can trigger cell proliferation in the skin. Consis-
tent with the multicomponent model of the Shh receptor,
activating Smo mutations have been identified in sporadic
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BCCs of patients who are wild-type for Ptc. Ectopic
expression of the mutant Smo proteins in transgenic mice
leads to skin abnormalities resembling BCCs, supporting
an oncogenic role for Smo in this syndrome [22].
Gli1, a member of the Gli family of zinc-finger transcrip-
tion factors [23,24] which includes Drosophila Cubitus inter-
ruptus (Ci), has been identified as a candidate downstream
mediator of the Shh response [25–29]. Gli1 is upregulated
in response to Shh [30,31] and was found to be consis-
tently upregulated in BCCs, indicating activation of the
Shh pathway in this type of tumor [32].
Despite the recent identification of Ptc as the Shh recep-
tor and the cloning of a number of components of the Hh
signal transduction pathway in Drosophila (reviewed in
[33]), the means by which the signal is transduced upon
binding of Shh to Ptc remain to be elucidated. Here, we
present functional evidence that Smo is the signaling
subunit of the Shh receptor and that Ptc represses Smo
signaling in the absence of Shh. Using chimeric receptors
of Smo with Fz-5, we have established that, as for most
typical GPCRs, the third intracellular (i3) loop and the
seventh transmembrane (TM) domain of Smo are impor-
tant for activation of a Gli reporter construct. In contrast,
interaction with Ptc requires mainly the amino-terminal
portion of the molecule.
Results
Activation of a Gli-binding-site reporter in response to Shh
and Smo
To study Shh signaling and the role of the Ptc–Smo recep-
tor complex, we used the mouse embryonic fibroblast cell
line C3H10T1/2, which undergoes osteoblast differentia-
tion in response to Shh as measured by alkaline phos-
phatase staining in Shh-stimulated cells [34] (Figure 1a).
Transfection of human Gli1 recapitulates the effect of Shh,
indicating that activation of Gli1 mediates the effect of Shh
in these cells (Figure 1a). To monitor Gli activation, we
generated a reporter construct consisting of nine copies of a
Gli-binding site (Gli-BS) present in the mouse HNF-3β
enhancer, upstream of the herpes simplex virus (HSV)
thymidine kinase (TK) minimal promoter and the
luciferase gene. To determine the specificity of the
response, we also constructed a reporter plasmid carrying a
mutated version of the Gli-binding site (mGli-BS) that is
unable to bind Gli and does not respond to Shh [35].
Cotransfection into C3H10T1/2 cells of the Gli-BS
reporter with a vector encoding full-length mouse Shh was
able to induce luciferase activity (Figure 1b) whereas trans-
fection of Shh with the mGli-BS plasmid resulted in back-
ground levels of induction, indicating that the response to
Shh was dependent on the presence of wild-type Gli-
binding sites. Similar results were obtained by stimulating
cells transfected with the Gli-BS reporter with recombi-
nant amino-terminal Shh (N-Shh) (data not shown). As
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Figure 1
Smo activates a Gli reporter construct. (a) C3H10T1/2 cells were
either untreated (control), treated with 50 nM recombinant N-Shh
(Shh), or transfected with a Gli1 expression construct. After 24 h, cells
were fixed for 2 min in methanol : acetone (50:50) and stained for
alkaline phosphatase with the alkaline phosphatase substrate kit
Vector Black (Vector Laboratories). (b,c) C3H10T1/2 cells were
transiently transfected with the reporter plasmids Gli-BS or mGli-BS
together with (b) expression constructs for Shh, Smo, Ptc or Gli1 or
(c) Smo mutants (Smo-M1 and Smo-M2) and deletion constructs
lacking the carboxy-terminal tail (∆C-term) or lacking the extracellular
domain (∆ECD) of Smo. The relative luciferase activity in cell lysates
was measured 48 h after transfection and was normalized to Renilla
luciferase activity (pRL-TK). Results are expressed as the mean
± standard deviation (SD) fold induction of duplicates from three
separate experiments.
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expected, strong induction of luciferase activity was
observed when the Gli-BS reporter was cotransfected with
a Gli1 expression plasmid (Figure 1b).
When human Smo was cotransfected into C3H10T1/2
cells with the Gli-BS reporter, it induced luciferase activ-
ity in a wild-type Gli-BS-dependent manner to an even
greater extent than Shh (Figure 1b). Two other seven-
transmembrane proteins, the human interleukin-8 recep-
tor (data not shown) and rat Fz-5 (Figures 2a,3a), were
unable to induce a response, indicating that Smo is a 
specific activator of the Shh pathway and that the
response cannot be triggered by unrelated seven-trans-
membrane proteins. Likewise, transfection of Ptc did 
not induce luciferase activity (Figure 1b), demonstrating
that ectopic expression of Ptc cannot activate the Shh 
signaling pathway.
Different domains of Smo are required for signaling and
Ptc interaction
In order to map the domain(s) of Smo required for signal-
ing, we generated several Smo deletion mutants as well as
chimeric receptors between human Smo and one of its
closest known homologues, Fz-5 (Figure 2). Smo deletion
constructs lacking either the amino-terminal extracellular
domain (ECD), or the carboxy-terminal cytoplasmic tail,
were tested for their ability to induce the reporter plasmid
(Figure 1c). Both constructs triggered activation of the
reporter, suggesting that these two domains are not
required for the signaling activity of Smo.
To generate Smo–Fz chimeric receptors, we replaced the
amino-terminal region of Smo with the corresponding
region of rat Fz-5, starting from the ECD and including
the first two TM domains (chimera 1), or the first four TM
domains (chimera 2). We also constructed the reverse
chimeras (chimeras 3 and 4) by replacing the carboxy-ter-
minal region of Smo with the corresponding one from Fz-5
(Figure 2). These four chimeric receptors were tested for
their ability to induce transcription from the Gli-BS
reporter (Figure 3a). Chimeras 1 and 2 were able to trigger
transcription of luciferase, whereas chimeras 3 and 4 failed
to activate transcription of the reporter gene although they
expressed at least as well as the first two chimeras
(Figure 3d). Together, these data demonstrate that the
region of Smo required to activate the Gli reporter spans
the i3 loop (including the adjacent fifth and sixth TM
domains) and the seventh TM domain (the carboxy-termi-
nal cytoplasmic tail not being required). Expression of
additional chimeric receptors containing only the i3 loop
without the seventh TM domain of Smo in Fz-5
(Fz–i3Smo), or the reverse chimera in Smo-M2
(M2–i3Fz), indicate that the presence of only one of these
two domains can lead to a receptor capable of Gli activa-
tion (Figure 3b). It would be interesting to determine the
signaling specificity of these chimeric receptors, because
similar swaps between muscarinic cholinergic and β-
adrenergic receptors leads to promiscuous signaling [36].
To determine which region(s) of Smo interact with Ptc,
we carried out coimmunoprecipitation experiments with
Ptc and the different Smo chimeras (Figure 3c,d). Smo, Fz
and the various chimeras run on SDS–polyacrylamide gels
as multimers, even under reducing conditions [12]. Smo
and chimeras 3 and 4 showed the strongest interaction
with Ptc. Chimeras 1 and 2 had a much lower affinity for
Ptc, and Fz-5 did not form a physical complex with Ptc.
These data suggest that (in contrast to Gli reporter activa-
tion, which requires motifs in the carboxy-terminal half of
Smo) the Ptc–Smo interaction occurs mainly through the
amino-terminal portion of Smo, with a less important con-
tribution provided by the rest of the molecule.
Ptc can block signaling by Smo
Ptc is a downstream target of Hh in both Drosophila [37]
and vertebrates [38] and its upregulation constitutes a
way to limit the response to Hh [39]. To analyze whether
Ptc is able to block Smo signaling, we cotransfected Ptc
from a green fluorescent protein (GFP) expression vector
(Ptc–GFP) with limiting amounts of Smo which was
epitope-tagged at its amino terminus (gD–Smo) [22].
Ptc–GFP/gD–Smo double-positive cells that express both
Ptc and Smo were isolated by cell sorting and processed
for measuring luciferase activity (Figure 4a). When coex-
pressed with Ptc, Smo was unable to transduce the signal
leading to Gli reporter activation (Figure 4b), supporting
a model in which Ptc prevents Smo signaling in the
absence of Shh. When Smo/Ptc double-positive cells
were sorted and then replated in the presence of 50 nM
recombinant N-Shh, the signaling activity of Smo was
restored (Figure 4c), demonstrating that the inhibitory
function of Ptc on Smo can be abrogated by the binding
of Shh to Ptc. This Shh-dependent increase in luciferase
activity was not observed in cells that were transfected
with Smo or Ptc alone, suggesting that endogenous Ptc
does not significantly inhibit Smo signaling in this assay
(data not shown).
Oncogenic Smo mutants and chimeras 1 and 2 are not
repressed by Ptc
To investigate whether Ptc was able to repress signaling
by chimeras 1 and 2, we cotransfected Ptc with limiting
amounts of Smo or chimeras 1 or 2 and sorted for double-
positive cells. Measurements of reporter activity in these
cells indicate that Ptc is able to repress signaling by Smo,
but not by chimeras 1 and 2 (Figure 4d), demonstrating
that different Smo domains are required for Ptc interac-
tion and Gli reporter activation.
Two Smo mutants (Smo-M1 and Smo-M2) were identi-
fied recently in sporadic BCCs. The mutation occurs in
the carboxy-terminal cytoplasmic tail for M1 (mutation of
78 Current Biology, Vol 9 No 2
Arg562 to Gln) and in the seventh TM domain for M2
(Trp535 to Leu). It has been shown that, in contrast to
wild-type Smo, these mutants trigger uncontrolled Smo
signaling in a foci assay and in transgenic mice [22]. When
tested in the luciferase assay for Gli reporter activation,
both Smo-M1 and Smo-M2 were able to induce luciferase
activity (Figure 1c). When coexpressed with Ptc, however,
Smo-M1 and Smo-M2 were still able to induce luciferase
activity, indicating that signaling by these mutants is not
repressed by Ptc (Figure 4b).
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Figure 2
(a) Sequence alignment of human Smo
versus rat Fz-5; the two proteins share 25.4%
similarity. Conserved amino acids are boxed
and the seven hydrophobic transmembrane
regions are marked in gray. The junctions of
the chimeric receptors are located in the
extracellular loops. For chimeras 1–4, these
junctions are marked with black arrows. For
the chimeric receptor containing only the i3
loop of Fz-5 in Smo-M2 (M2–i3Fz), junctions
are marked with gray arrows. For the chimeric
receptor containing only the i3 loop of Smo in
Fz-5 (Fz–i3Smo), junctions are marked with a
gray arrow and a gray asterisked arrow. The
beginning of the deletion construct lacking the
ECD and the end of the carboxy-terminal
deletion construct are marked with white
arrows. (b) Schematic representation of the
Smo–Fz-5 chimeras. The region
corresponding to Smo is shown in blue and
the region corresponding to Fz-5 in yellow.
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Shh signaling in C3H10T1/2 cells is not mediated by cAMP
or calcium
Because the Smo sequence predicts it to be a member of
the superfamily of GPCRs and Gli reporter activation is
mediated by domains typically involved in coupling to G
proteins, we tested whether transduction of the Shh signal
involved second messengers typically linked to G-protein
activation. In these experiments, we examined the
response either in wild-type C3H10T1/2 cells or in cells
cotransfected with Ptc and Smo. No increase in the level
of intracellular cAMP was detected when wild-type or
transfected cells were stimulated with recombinant N-
Shh. Similarly, no significant inhibition of forskolin-stimu-
lated accumulation of cAMP was detected in response to
N-Shh (Figure 5a,b). We also measured the intracellular
calcium ion (Ca2+) concentration in response to N-Shh as a
readout for generation of inositol-1,4,5-trisphosphate. In
contrast to the muscarinic acetylcholine receptor agonist
carbachol and the Ca2+ ionophore ionomycin, no changes
were detected after stimulation of cells with various con-
centrations of N-Shh (Figure 5c,d). Similar data were
obtained by directly measuring the concentration of phos-
phatidylinositols (data not shown).
Discussion
Smo is the signaling component of the Shh receptor
The Shh receptor represents a novel paradigm and little
was known of the mechanism by which it signals upon
binding of its ligand. We have shown here that in a reporter
assay for Gli activation, human Smo acts as the signaling
component of the Shh receptor. These findings support
genetic data in Drosophila, where Hh target genes are tran-
scribed in a Hh Ptc double mutant, but not in a Smo Ptc
double mutant [10,40]. Gli reporter activation by ectopic
Smo expression suggests an agonist-independent mecha-
nism of action for Smo. Nevertheless, our results do not
exclude the possibility that a putative Smo ligand further
modulates Smo signaling. It is unlikely that the constitu-
tive Smo signaling observed in our assay is due to the pres-
ence of this ligand, because a Smo construct lacking most
of the amino-terminal ECD is still able to activate the Gli
reporter. Interestingly, injection of the Smo-related seven-
transmembrane protein rat Fz-2 in zebrafish embryos also
triggers a response, and this can be further enhanced by
coinjection of the Fz ligand Xwnt-5a [41]. 
Domains of Smo implicated in signaling
In well-characterized GPCRs, the i3 loop is the most criti-
cal region for interaction with G proteins; the second intra-
cellular (i2) loop and the carboxyl terminus are also
involved, but to a lesser extent (reviewed in [42]). Chimeric
receptors containing the i2 and i3 loops and the carboxyl
terminus of Smo, or just the i3 loop and the carboxyl termi-
nus, were able to signal in our assay. Nevertheless, chimeric
receptors in which only the i3 loop of Smo was replaced in
Fz-5 or in which the i3 loop of Fz was introduced in Smo-
M2 were both active. Interestingly, similar experiments
using chimeras constructed from receptors with different
G-protein-coupling specificities lead to promiscuous 
G-protein coupling [36]. It would be interesting, therefore,
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Figure 3
Reporter activation and binding to Ptc of the
Smo–Fz-5 chimeras. (a,b) Luciferase activity
in cells transfected with the different
Smo–Fz-5 chimeric receptors (see Figure 2b).
The efficiency of transfection was normalized
to Renilla luciferase. The data represent the
mean ± SD fold induction of duplicates from
three different experiments. (c,d) Co-
immunoprecipitations of Ptc and Smo–Fz-5
chimeras. COS-1 cells were transfected with
2 µg of Ptc–FLAG and 2 µg of Smo–Myc,
Fz-5–Myc or Myc-tagged chimeras 1–4
(Ch1–4). Immunoprecipitations (IPs) were
carried out with anti-FLAG (αFLAG) or anti-
Myc (αMyc) antibodies and blots probed with
anti-Myc antibodies. 
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to determine whether the Smo chimeras described here are
also able to activate the Fz pathway.
Protein kinase A (PKA) is an antagonist of the Hh pathway
in both Drosophila [43,44] and vertebrate cells [45]. PKA
could potentially impinge on the Hh pathway at several
levels: the carboxyl terminus of Smo contains PKA phos-
phorylation sites which might be important in regulating
the desensitization/turning over of the protein [10,11]; in
Drosophila, PKA controls the processing of Ci from an acti-
vator form to a repressor form [46]; and finally, the cAMP
responsive element binding protein (CREB) binding
protein (CBP), a cofactor for Ci, is activated by PKA
(reviewed in [47]), suggesting that competition for CBP
binding between Ci and CREB might regulate the activa-
tion of Hh target genes [48]. Although it is tempting to
speculate that Smo couples to a trimeric G protein and
controls the activity of PKA through the levels of cAMP,
we have not been able to detect any change in intracellu-
lar cAMP or Ca2+ (or phosphatidylinositol) levels in
C3H10T1/2 cells stimulated with N-Shh. Consistent with
these findings, it was reported that Hh can signal normally
in cells carrying an altered form of PKA that is insensitive
to cAMP concentrations [49]. A possible interpretation of
these results would be that the signal is transduced either
through the Gβγ subunits of a trimeric G protein or
through a novel mechanism.
Ptc blocks signaling by Smo
Vertebrate Ptc binds Shh with high affinity and forms a
complex with Smo [12]. Here, we demonstrate that coex-
pression of Ptc can block Smo signaling, and that addition
of recombinant N-Shh is sufficient to restore activation of
the Gli reporter. These data provide functional evidence
for a model in which Ptc is the ligand-binding subunit and
Smo is the signaling subunit of a multicomponent Shh
receptor. The function of Ptc would be to sequester Smo
and prevent it from signaling in the absence of Shh. Upon
binding of Shh to Ptc, the inhibition of Smo is released
and Smo can start signaling. These data are consistent
with epistasis analyses in Drosophila, where Smo was
shown to act downstream of Ptc, and with a model of
human BCCs, where loss of both copies of Ptc results in
unrestricted Smo signaling.
Smo mutants are not repressed by Ptc
Whereas the i3 loop and the seventh TM domain of Smo
are important for signaling, the amino-terminal part of the
protein might be critical for binding to Ptc, as shown by the
lower levels of chimeras 1 and 2 that coimmunoprecipitate
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Figure 4
Ptc inhibits Smo signaling. (a) Identification of
GFP/gD double-positive cells by
fluorescence-activated cell sorting (FACS)
analysis in C3H10T1/2 cells cotransfected
with gD–Smo and the Ptc–GFP plasmid.
(b) C3H10T1/2 cells were transfected with
effector plasmids as indicated and sorted for
gD/GFP double-positive cells 48 h after
transfection. Equal numbers of sorted cells
were then lysed, and luciferase activity was
measured. When expressed in limiting
amounts, gD–Smo-M1 (Smo-M1) and
gD–Smo-M2 (Smo-M2) produced
consistently slightly reduced reporter activities
compared to gD–Smo (Smo). (c) Cells
transfected with gD–Smo, Ptc–GFP (Ptc) and
the reporters were sorted 48 h after
transfection and equal amounts of positive
cells were replated in the presence or
absence of 50 nM recombinant N-Shh for an
additional 14 h; cells were then lysed and
luciferase activity measured. Data represent
the mean ± SD of duplicate determinations
from a representative experiment out of three.
(d) Cells were transfected with different
combinations of effector plasmids as
indicated. After 48 h, cells double-positive for
blue fluorescent protein (BFP) and GFP were
sorted and reporter activity was measured.
Data represent the mean ± SD of duplicate
determinations from two representative
experiments.
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with Ptc. As the Smo construct lacking the amino-terminal
ECD was coimmunoprecipitated with Ptc at similar levels
to full-length Smo (data not shown), we concluded that the
region spanning residues 218 (the beginning of the amino-
terminal ECD truncation construct) to 295 (the junction
between Fz and Smo in chimera 1) might contain the main
Ptc–Smo interaction site(s). Although chimeras 1 and 2
have a lower affinity for Ptc, they are capable of signaling
as well as wild-type Smo and are not blocked by coexpres-
sion of Ptc, indicating that different regions of Smo are
responsible for Ptc interaction and activation of down-
stream signaling. Point mutations in the amino terminus
might not be sufficient to disrupt the Ptc–Smo interface,
however, and we did not identify such mutations in a
screen of 47 sporadic BCCs [22].
The two mutant Smo molecules that were identified in
sporadic BCCs, Smo-M1 and Smo-M2, are capable of acti-
vating Gli as measured by our reporter assay and bind nor-
mally to Ptc [22], as predicted by the chimeric receptors
analyzed above. When Ptc was coexpressed with these
mutant Smo proteins, though, activation of the Gli
reporter gene could not be blocked. These data provide
evidence that specific mutations in the carboxyl terminus
can uncouple Smo signaling from repression by Ptc
despite a strong interaction between the two molecules.
These mutations may be locking the receptor in a confor-
mation that mimics the active form despite the presence
of bound Ptc. Although Smo-M1 is found less frequently
and is a less potent oncogene in our hands, its oncogenic
activity is more difficult to explain, because a Smo con-
struct lacking the carboxy-terminal cytoplasmic region was
still able to fully activate the Gli reporter. The carboxy-
terminal region of GPCRs plays a role in desensitization of
the receptor and carries endocytic signals required for
sequestering (reviewed in [50]). Therefore, mutation in
the cytoplasmic tail such as that found in Smo-M1 may
affect receptor desensitization or sequestration. Unravel-
ing the mechanisms by which Ptc controls Smo signaling
may lead to the development of molecules that are phar-
macologically useful for the treatment of BCCs or other
pathologies caused by loss of Ptc function.
Conclusions
Our results provide direct functional evidence that Smo is
the signaling component of the Shh receptor complex and
that its activity can be repressed by Ptc in a ligand-depen-
dent manner. Therefore, Ptc exerts its tumor suppressing
activity by controlling Smo signaling and loss of Ptc func-
tion leads to unregulated Smo signaling, a common occur-
rence in BCCs. Alternatively, oncogenic Smo mutations
have been identified and are shown here to be insensitive
to Ptc repression, although they are still able to form a
complex with Ptc. Our analysis indicates that different
regions of Smo are involved in activating the Gli pathway
and in binding to Ptc. Considering their locations, the Smo
mutations are likely to interfere with signaling or desensi-
tization of the receptor. Further analysis of the amino-ter-
minal region of Smo in BCCs may lead to the
identification of oncogenic mutations disrupting the
binding of Smo to Ptc.
Material and methods
Expression constructs and chimeras
Human Smo, Smo-M1 and Smo-M2 were tagged with the gD epitope
from HSV [51] at their amino terminus by PCR-based mutagenesis using
Pfu DNA polymerase (Stratagene), and cloned into pRK5 under the
control of the cytomegalovirus (CMV) promoter. For cotransfection exper-
iments, human Ptc was cloned into a CMV-based expression vector
coexpressing the enhanced GFP (Clontech) from a CMV promoter.
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Figure 5
Intracellular cAMP and Ca2+ in C3HT101/2 cells stimulated with N-
Shh. (a) Untransfected cells or (b) cells cotransfected with human Ptc
and Smo were stimulated with no ligand or 500 nM N-Shh in the
absence or presence of 5 µM forskolin and analyzed for production of
intracellular cAMP and inhibition of adenylate cyclase. (c,d) Time
course of the accumulation of Ca2+ mediated by N-Shh, carbachol or
ionomycin in (c) untransfected C3HT101/2 cells or (d) transfected
cells expressing human Ptc and Smo. 
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Human Smo–rat Fz-5 chimeric receptors were generated by PCR using
Pfu DNA polymerase (Stratagene). Primers spanning the Smo and Fz-5
regions of each chimera were used to amplify different Smo and Fz-5
fragments, the PCR products were then gel purified and used as tem-
plate to amplify, with flanking primers, the entire chimeras. A Myc epitope
was added to the carboxyl terminus of every chimera. All the constructs
were checked by sequencing.
Luciferase assay
The reporter plasmids Gli-BS and mGli-BS were constructed by
placing nine copies of a Gli-binding site element present in the mouse
HNF-3β enhancer, or a mutated version of it [35], in front of the HSV
TK promoter in the plasmid pGL3-Basic (Promega). C3H10T1/2 cells
were seeded into six-well plates at 9 × 104 cells/well the day before
transfection. Cells were transfected with 1 µg reporter, 1 µg expression
plasmid, and 0.0025 µg reference plasmid (pRL-TK, Promega) using
lipofectamine (Gibco BRL). Reporter gene activity was determined
48 h after transfection with the Dual-Luciferase Reporter Assay System
(Promega). Normalization of transfection efficiencies was carried out
using Renilla luciferase activities. All reporter assay experiments were
repeated at least three times, and transfections done in duplicates.
Immunoprecipitations
For coimmunoprecipitation experiments COS-1 cells were transiently
transfected with the various expression plasmids in 10 cm plates by
electroporation. 36 hours after transfection cells were collected and
lysed 20 min on ice in 1 ml of 1% NP-40 lysis buffer containing 50 mM
Tris (pH 8.0), 150 mM NaCl, 1 mM EDTA, 1 mM PMSF and protease
inhibitors (Complete, Boehringer Mannheim). Cell debris were removed
by centrifugation at 10,000 rpm and the supernatant precleared for 1 h
with 15 µl protein G–Sepharose (Pharmacia). Lysates were immuno-
precipitated using anti-FLAG M2 (Kodak) or anti-Myc (9E10) antibod-
ies followed by protein G–Sepharose, and washed three times with
lysis buffer, three times with lysis buffer containing 1 M NaCl, and then
again three times with lysis buffer. Samples were run on a denaturing
6% SDS–polyacrylamide gel, transferred to a nitrocellulose membrane
and probed with antibodies to the Myc epitope followed by a horserad-
ish-peroxidase-conjugated sheep anti-mouse immunoglobulin (Amer-
sham). The blots were developed using the enhanced
chemiluminescence detection system (Amersham).
Cytofluorometry combined reporter assay
C3H10T1/2 cells seeded in 15 cm plates were transfected 24 h after
plating with 3 µg of gD–Smo, 6 µg of Ptc–GFP or control GFP vector,
8 µg of reporter plasmid, and 0.01 µg pRL-TK. 48 h after transfection
1 × 106 cells were labeled for FACS analysis with an anti-gD mono-
clonal antibody as described previously [52] and gD/GFP double-posi-
tive cells were sorted with an Epics Elite cell sorter (Coulter). Equal
amounts of double-positive cells were then either directly lysed and
processed for luciferase activity, or replated in presence of 50 nM
recombinant N-Shh for an additional 14 h and then lysed. A similar pro-
tocol was used to sort for Ptc/chimera 1 or 2 double-positive cells,
except that cells were cotransfected with 6 µg of Ptc–GFP or control
GFP and 2 µg of Smo, chimeras 1 or 2 cloned in a blue fluorescent
protein (BFP) expression vector (Smo–BFP, Ch1–BFP and Ch2–BFP).
BFP/GFP double-positive cells were sorted and processed for
luciferase activity. Luciferase activity was measured with the Dual-
Luciferase Reporter Assay System (Promega), and values were normal-
ized using Renilla luciferase activity. All experiments were repeated at
least three times.
cAMP assay
To quantify intracellular cAMP, cells were either directly plated at a
density of 1 × 105 cells/well the day before the assay, or transfected
24 h before stimulation with 1 µg Ptc and 1 µg Smo in six-well plates.
Prior to addition of the ligand, cells were equilibrated for 15 min at
37°C in serum-free medium containing 100 µM isobutylmethylxanthine
(Calbiochem). N-Shh (500 nM) was then added in the presence or
absence of 5 µM forskolin (Sigma), and incubation was continued for
another 10 min. To isolate cAMP, cells were lysed with ice cold 10%
TCA, and cell extracts separated by chromatography on Amprep SAX
columns (Amersham), according to the manufacturer’s instructions.
The cAMP concentrations were determined by 125I scintillation proxim-
ity assay (Amersham).
Analysis of intracellular Ca2+ concentration
C3HT101/2 cells untransfected or cotransfected with Ptc/Smo were
plated the day before stimulation at a density of 4 × 103 cells/well in
96-well plates. Cells were washed three times in Hank’s balanced salt
solution (HBSS) and loaded with 4 µM Fluo-3/AM (Molecular Probes)
for 45 min at 37°C. Cells were then washed extensively with HBSS
and stimulated with 250 nM, 500 nM or 1 µM N-Shh, 50 µM iono-
mycin, or 1 mM carbachol. Real time changes in intracellular Ca2+ con-
centration following addition of the ligand were measured with a
Fluorometric imaging plate reader (Molecular Devices).
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